For full-year 2024, Elevance reported $175.2 billion in revenue, an increase of 2.9% over its $170.2 billion haul in 2023.

Elevance (ELV) stock thrives with fee-based plans, preventive care, and disciplined capital management, ensuring growth and strong investor returns. See more.

Elevance Health recently faced shareholder proposals aimed at increasing transparency in its diversity, equity, and inclusion initiatives. Over the last quarter, the company's stock price ...

Elevance continues to expect its Medicare Advantage program to hit 2.2 million to 2.25 million members in 2025, and for adjusted earnings to be $34.15 to $34.85 a share.

In a regulatory filing, Elevance Health (ELV) noted it will release its first quarter 2025 financial results on April 22. “First quarter ...

Elevance Health on Thursday forecast a first-quarter profit above estimates and maintained its annual profit view, hours after industry bellwether UnitedHealth cut its outlook and sparked a selloff in ...

In a regulatory filing, Elevance Health (ELV) noted it will release its first quarter 2025 financial results on April 22. The company expects ...

Elevance Health Stock Up 0.3 % Elevance Health stock opened at $441.02 on Tuesday. The stock has a 50 day moving average of $413.71 and a two-hundred day moving average of $411.99. Elevance Health ...

Elevance Health recently faced shareholder proposals aimed at increasing transparency in its diversity, equity, and inclusion initiatives. Over the last quarter, the company's stock price increased by ...

According to Benzinga Pro, Elevance Health's peer group average for short interest as a percentage of float is 4.67%, which means the company has less short interest than most of its peers. Did you ...

Shares of Elevance Health, Inc. (ELV) were in the spotlight on Thursday afternoon after the company said it expects to report ...